Patent ID: 11920136
Assignee: TALLAC THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. An immunomodulating oligonucleotide of Formula (C):, , wherein
* and ** indicate the points of attachment within the oligonucleotide;
each T1 is independently O or S;
each T2 is S−;
T3 is a group, wherein  indicates the point of attachment to the rest of the oligonucleotide;
Z is O or S;
U5′ is —H or halogen;
R5′ is —H or methoxy;
Rc1 is —H or methoxy;
Rg1, Rg2, Rg3, and V are H;
R3′ is methoxy;
R1 is —(CH2)3—OH;
R2 is —H or methyl; and
n is an integer from 0 to 2,, or a pharmaceutically acceptable salt thereof.